Sorry, you need to enable JavaScript to visit this website.

Skip to main content

Search

eMeds: The Future of Clinical Trial Data

eMeds: Integrated Platform to Transform Medication & Adherence Management

The current system for managing clinical supplies is inefficient. Patients must search through multi‐language medication label booklets for dosing instructions, and doses are often forgotten or incorrectly taken, with non‐adherence frequently going unrecognized. Investigators also spend valuable time on manual data entry, and for sponsor companies labeling and relabeling clinical supplies is cumbersome and costly.

The eMeds platform uses smart technologies, such as smartphones, smart medication packages and medication scanners, to transform how clinical supplies are managed with the goal of increasing operational efficiency as well as patient compliance. A technical pilot study has been completed to test all functionalities of the eMeds platform and evaluate the effectiveness and user friendliness of the smart technology components with a range of potential users, and the results were encouraging.

Currently, Clinical Trial Innovation and its partners are actively developing a more robust eMeds technology platform that can be fully integrated into internal and external systems and/or be used on a patient’s personal cell phone, as well as developing additional smart medication packaging formats. Multiple pharma companies and cross-industry consortiums have been engaged in the platform-development discussions.

For more information regarding potential collaborations or participating in ongoing projects, contact [email protected].

Clinical Trials

Clinical Trials

Donna Williams, Discovery
Donna Williams, Discovery